Literature DB >> 4041342

Selectivity and dose-dependency of the inhibitory effect of propranolol on theophylline metabolism in man.

J O Miners, L M Wing, K J Lillywhite, R A Robson.   

Abstract

The effects of separate 5 day pretreatments of propranolol 120 mg day-1 and 720 mg day-1 on theophylline clearance and metabolism at steady-state were determined in seven healthy males. Propranolol 120 mg day-1 decreased theophylline plasma clearance (CL) by 30%. Clearance of theophylline to each metabolite was reduced by this treatment, clearances to the two demethylated products by 42-43% and clearance to the 8-hydroxylation product by 27%. Propranolol 720 mg day-1 decreased theophylline CL by 52%. Again, clearance of theophylline to each metabolite was reduced by this treatment, clearances to the two demethylation products by 73-77% and clearance to the 8-hydroxylation product by 44%. These data are consistent with a dose-dependent and selective inhibitory effect of propranolol on the separate forms of cytochrome P-450 involved in theophylline demethylation and 8-hydroxylation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4041342      PMCID: PMC1400697          DOI: 10.1111/j.1365-2125.1985.tb05064.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

1.  Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients.

Authors:  M Peet; D N Middlemiss; R A Yates
Journal:  Lancet       Date:  1980-11-01       Impact factor: 79.321

2.  Effect of propranolol on pharmacokinetics and acute electrocardiographic changes following intravenous quinidine in humans.

Authors:  H R Ochs; D J Greenblatt; E Woo; K Franke; T W Smith
Journal:  Pharmacology       Date:  1978       Impact factor: 2.547

3.  The simultaneous determination of theophylline, theobromine and caffeine in plasma by high performance liquid chromatography.

Authors:  T Foenander; D J Birkett; J O Miners; L M Wing
Journal:  Clin Biochem       Date:  1980-06       Impact factor: 3.281

4.  Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol.

Authors:  H R Ochs; G Carstens; D J Greenblatt
Journal:  N Engl J Med       Date:  1980-08-14       Impact factor: 91.245

5.  Effects of metoprolol and propranolol on theophylline elimination.

Authors:  K A Conrad; D W Nyman
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

6.  Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.

Authors:  N D Bax; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of propranolol.

Authors:  P A Routledge; D G Shand
Journal:  Clin Pharmacokinet       Date:  1979 Mar-Apr       Impact factor: 6.447

8.  The inhibition of rat hepatic microsomal propranolol metabolism by a covalently bound reactive metabolite.

Authors:  J F Pritchard; D W Schneck; A H Hayes
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1980-02

9.  Cigarette smoking and theophylline clearance and metabolism.

Authors:  J J Grygiel; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1981-10       Impact factor: 6.875

10.  Impairment of antipyrine clearance in humans by propranolol.

Authors:  D J Greenblatt; K Franke; D H Huffman
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

View more
  11 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

2.  Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessment.

Authors:  Thomas M Polasek; Frank P Y Lin; John O Miners; Matthew P Doogue
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

3.  Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects.

Authors:  N Brion; E Naline; D Beaumont; M Pays; C Advenier
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 4.  Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.

Authors:  U Tröger; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

5.  Metabolism of theophylline by cDNA-expressed human cytochromes P-450.

Authors:  H R Ha; J Chen; A U Freiburghaus; F Follath
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

6.  Lack of effect of atenolol on the pharmacokinetics of theophylline.

Authors:  L A Cerasa; J S Bertino; E A Ludwig; M Savliwala; E Middleton; R L Slaughter
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

7.  Characterisation of theophylline metabolism in human liver microsomes.

Authors:  R A Robson; A P Matthews; J O Miners; M E McManus; U A Meyer; P M Hall; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

8.  Enoxacin--a potent inhibitor of theophylline metabolism.

Authors:  J Beckmann; W Elsässer; U Gundert-Remy; R Hertrampf
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

9.  The effect of propranolol on paracetamol metabolism in man.

Authors:  O Z Baraka; C A Truman; J M Ford; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

10.  Lack of effect of atenolol and nadolol on the metabolism of theophylline.

Authors:  C M Corsi; A N Nafziger; J A Pieper; J S Bertino
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.